CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Organigram

Ivan Salazar, Plant Production Manager

The Impact of COVID-19 on Cannabis Consumption: Trends and Future Projections

Ivan Salazar

Ivan Salazar

Ivan Salazar is an experienced professional in biotechnology and production management, currently serving as the Plant Production Manager at Organigram Inc. He holds a Bachelor of Science from the University of Manitoba and a Diploma in Biochemical Technology from Red River Polytechnic College.


With over 20 years in the industry, Salazar 's career includes roles such as Production Manager at Novopharm Biotech Inc. and Cangene Corp., and Director of Manufacturing at Viventia Biotech Inc. He has also served as Operations Excellence Project Manager at Cangene and Supervisor at Freshwater Fish Marketing Corporation. Most recently, he was the Production Manager at Wonderbrands before joining Organigram.


Salazar is dedicated to driving efficiency and quality in production processes, leveraging his extensive experience to contribute to the success of Organigram.


The COVID-19 pandemic has transformed various aspects of daily life, leading to changes in consumer behaviour across multiple industries. Among these, the cannabis market has experienced notable shifts in consumption patterns and attitudes. As legalization efforts gain momentum and public interest in cannabis grows, understanding the dynamics of consumption during this unprecedented time offers valuable insights into future trends.


Cannabis Consumption during the COVID-19 Pandemic


As the pandemic unfolded in early 2020, many consumers turned to cannabis as a means of coping with stress, anxiety, and the uncertainties of lockdown measures. Reports from various states and countries showed a significant spike in cannabis sales, particularly in the United States. Data from head shops, dispensaries, and online retailers revealed that many consumers stocked up on cannabis products as stay-at-home orders came into effect. According to a survey conducted by the cannabis analytics firm, Headset, sales in March 2020 have surged by 30 percent compared to the previous year.


Several factors contributed to this increase in consumption. First, as social isolation took hold, individuals sought alternatives for relaxation and entertainment. Cannabis, often viewed as a natural remedy for anxiety and stress, became a popular choice. The National Institute on Drug Abuse noted increases in cannabis use among those reporting heightened stress levels during the pandemic. Moreover, the closure of recreational venues and events led to a shift in social consumption patterns, with individuals opting to consume cannabis in the comfort of their homes. The rise of virtual gatherings and online socialization further facilitated this trend, as people sought ways to connect with friends and loved ones.


Demographic Shifts in Cannabis Consumption


The pandemic also brought about changes in the demographics of cannabis consumers. Traditionally, the cannabis market was dominated by younger adults, but recent trends show a widening appeal across age groups. A study by the Pew Research Center highlighted that adults aged 50 and above have increasingly reported using cannabis for both medicinal and recreational purposes. Many of these older consumers are turning to cannabis for pain management, anxiety relief, and sleep disorders, which have become more prevalent during the pandemic due to increased stress and altered routines.


This demographic shift suggests that the cannabis industry may continue to expand its customer base, catering to a more diverse population. Additionally, as more states legalize cannabis, older adults may feel more comfortable exploring its benefits, further normalizing its use in society.


The evolving landscape indicates that cannabis will increasingly be viewed as a wellness product rather than just a recreational substance.


Current Consumption Levels and Market Insights


As of 2023, the cannabis market has stabilized, but consumption levels remain elevated compared to pre-pandemic figures. According to industry reports, the global legal cannabis market was valued at approximately $20 billion in 2022, with projections estimating it to reach $70 billion by 2028. This growth highlights the sustained interest in cannabis and the potential for further market expansion.


Product preferences have shifted towards edibles and beverages, with consumers increasingly seeking discreet and convenient consumption methods. The pandemic has accelerated this trend as many individuals prefer products that can be consumed without the need for smoking, reducing health concerns related to respiratory issues. The rise of cannabis-infused beverages, which allow for social consumption without the stigma traditionally associated with cannabis, has opened new avenues for market growth.


The pandemic also accelerated the trend towards online purchasing and delivery services, as many consumers preferred the convenience and safety of ordering cannabis products from home. The rise of subscription services and cannabis delivery apps has made it easier for consumers to access their preferred products, further embedding cannabis into the fabric of everyday life. According to a report by BDS Analytics, e-commerce sales of cannabis products increased by over 200% during the pandemic, a trend that is likely to persist as consumers become accustomed to the convenience of online shopping.


 

As consumers embrace the myriad benefits of cannabis, the future of consumption holds promise for a thriving industry that is increasingly becoming a fundamental part of modern life


Implications for Future Cannabis Consumption


The consumption trends seen during the pandemic provide valuable insights into the future landscape of the cannabis market. As legalization continues to spread across various regions, it is reasonable to estimate that cannabis consumption will continue to rise. The normalization of cannabis use, coupled with changing societal attitudes, suggests that more individuals will explore cannabis for both recreational and medicinal purposes.


Moreover, the ongoing emphasis on wellness and self-care could influence future consumption patterns. Consumers are increasingly seeking natural alternatives to pharmaceutical medications, and cannabis, particularly CBD products, is positioned to meet this demand. Public health campaigns highlighting the therapeutic benefits of cannabis may further encourage its acceptance among those who may have been hesitant in the past.


Additionally, as research into the medical benefits of cannabis expands, we may see an influx of new products tailored to specific health concerns. This could lead to a more informed consumer base that seeks targeted solutions, such as cannabis products designed for anxiety relief, pain management, or sleep enhancement.


Conclusion


The COVID-19 pandemic has undeniably shaped the landscape of cannabis consumption, leading to increased sales, demographic shifts, and evolving product preferences. As we move beyond the pandemic, the cannabis industry appears poised for continued growth, supported by changing consumer attitudes, expanding markets, and innovative product offerings. Understanding these trends and their implications will be crucial for stakeholders in the cannabis sector as they navigate the evolving landscape and prepare for the future of consumption.


The pandemic has accelerated existing trends while also paving the way for a more integrated and mainstream acceptance of cannabis in society. As consumers embrace the myriad benefits of cannabis, the future of consumption holds promise for a thriving industry that is increasingly becoming a fundamental part of modern life. With evolving regulations, enhanced product offerings, and a growing consumer base, the cannabis industry is set to flourish in the future.


This growth signifies not just a shift in consumer behaviour but also a redefined perception of cannabis that reflects broader societal changes, paving the way for a more informed, responsible, and health-conscious approach to cannabis consumption.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://peptides.lifesciencesreview.com/leadership-perspective/the-impact-of-covid19-on-cannabis-consumption-trends-and-future-projections-nwid-2162.html